Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Drug and Alcohol Review|October 27, 2015
Substance use, health status and service utilisation of older clients attending specialist drug and alcohol servicesNicholas Lintzeris, Consuelo Rivas, Lauren A Monds, et al.
The Medical Journal of Australia|July 2, 2003
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trialAmy E Gibson, Christopher M Doran, James R Bell, et al.
Pain Medicine (Malden, Mass.)|September 11, 2019
Acute Experimental Pain Responses in Methadone- and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot StudyBridin Patricia Murnion, Consuelo Rivas, Apo Demirkol, et al.
BMC Public Health|February 2, 2024
The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational studyBenjamin T Trevitt, Victoria Hayes, Rachel Deacon, et al.
Drug and Alcohol Review|May 8, 2015
The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulationsBriony Larance, Paul Dietze, Robert Ali, et al.
Addiction (Abingdon, England)|November 18, 2003
A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in AustraliaAlison J Ritter, Nicholas Lintzeris, Nicolas Clark, et al.
Harm Reduction Journal|September 28, 2006
Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UKNicholas Lintzeris, John Strang, Nicola Metrebian, et al.
Drug and Alcohol Review|September 4, 2025
Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community-Based Outpatient Treatment Centres in AustraliaJamie Bryant, Anthony Shakeshaft, Nicholas Lintzeris, et al.
Addiction (Abingdon, England)|January 19, 2010
The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinicParameswaran Ramasamy, Nicholas Lintzeris, Yvonne Sutton, et al.
Pharmacoepidemiology and Drug Safety|October 1, 2015
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodoneAmy Peacock, Louisa Degenhardt, Briony Larance, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Drug and Alcohol Review|October 27, 2015
Substance use, health status and service utilisation of older clients attending specialist drug and alcohol servicesNicholas Lintzeris, Consuelo Rivas, Lauren A Monds, et al.
The Medical Journal of Australia|July 2, 2003
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trialAmy E Gibson, Christopher M Doran, James R Bell, et al.
Pain Medicine (Malden, Mass.)|September 11, 2019
Acute Experimental Pain Responses in Methadone- and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot StudyBridin Patricia Murnion, Consuelo Rivas, Apo Demirkol, et al.
BMC Public Health|February 2, 2024
The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational studyBenjamin T Trevitt, Victoria Hayes, Rachel Deacon, et al.
Drug and Alcohol Review|May 8, 2015
The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulationsBriony Larance, Paul Dietze, Robert Ali, et al.
Addiction (Abingdon, England)|November 18, 2003
A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in AustraliaAlison J Ritter, Nicholas Lintzeris, Nicolas Clark, et al.
Harm Reduction Journal|September 28, 2006
Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UKNicholas Lintzeris, John Strang, Nicola Metrebian, et al.
Drug and Alcohol Review|September 4, 2025
Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community-Based Outpatient Treatment Centres in AustraliaJamie Bryant, Anthony Shakeshaft, Nicholas Lintzeris, et al.
Addiction (Abingdon, England)|January 19, 2010
The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinicParameswaran Ramasamy, Nicholas Lintzeris, Yvonne Sutton, et al.
Pharmacoepidemiology and Drug Safety|October 1, 2015
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodoneAmy Peacock, Louisa Degenhardt, Briony Larance, et al.
Pageof 20